ELAC2 antibody
-
- Target See all ELAC2 Antibodies
- ELAC2 (ElaC Homolog 2 (ELAC2))
-
Reactivity
- Human, Mouse, Rat
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This ELAC2 antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- Characteristics
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogen
- Recombinant fusion protein of human ELAC2 (NP_776065.1).
- Isotype
- IgG
-
-
- Application Notes
- WB 1:500-1:2000 IHC 1:50-1:200 IF 1:50-1:100
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- ELAC2 (ElaC Homolog 2 (ELAC2))
- Alternative Name
- ELAC2 (ELAC2 Products)
- Synonyms
- 1110017O07Rik antibody, D11Wsu80e antibody, Hpc2 antibody, ELC2 antibody, HPC2 antibody, elaC ribonuclease Z 2 antibody, ELAC2 antibody, Elac2 antibody
- Background
- The protein encoded by this gene has a C-terminal domain with tRNA 3' processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene.
- Molecular Weight
-
Observed_MW: 105 kDa
Calculated_MW: 50 kDa/56 kDa/87 kDa/92 kDa
- Gene ID
- 60528
- UniProt
- Q9BQ52
-